{"component": "definition", "props": {"groups": [{"size": 48, "samples": [{"hash": "56xqS1ciy4a", "uri": "/contracts/56xqS1ciy4a#fte-cost", "label": "Patent and Know How License Agreement", "score": 31.3408622742, "published": true}, {"hash": "fws7229aM3A", "uri": "/contracts/fws7229aM3A#fte-cost", "label": "Patent and Know How License Agreement (Zoetis Inc.)", "score": 24.2361392975, "published": true}, {"hash": "dqgq6RpJIms", "uri": "/contracts/dqgq6RpJIms#fte-cost", "label": "Patent and Know How License Agreement (Zoetis Inc.)", "score": 24.2361392975, "published": true}], "snippet": "means, for any period, the FTE Rate multiplied by the applicable number of FTEs in such period.", "snippet_links": [{"key": "fte-rate", "type": "definition", "offset": [27, 35]}, {"key": "number-of", "type": "clause", "offset": [65, 74]}], "hash": "709767eb4306b94a8247daa62dc4a0e9", "id": 1}, {"size": 39, "samples": [{"hash": "h0AzpZRcyWC", "uri": "/contracts/h0AzpZRcyWC#fte-cost", "label": "Research Collaboration and Co Development Agreement (NextCure, Inc.)", "score": 34.2176589966, "published": true}, {"hash": "7mJlLFMNyyV", "uri": "/contracts/7mJlLFMNyyV#fte-cost", "label": "Collaboration and License Agreement (Verve Therapeutics, Inc.)", "score": 33.8487319946, "published": true}, {"hash": "aSTf5Nj08py", "uri": "/contracts/aSTf5Nj08py#fte-cost", "label": "Collaboration and License Agreement (Prime Medicine, Inc.)", "score": 33.0301170349, "published": true}], "snippet": "means, for any period, the FTE Rate multiplied by the number of FTEs in such period.", "snippet_links": [{"key": "fte-rate", "type": "definition", "offset": [27, 35]}, {"key": "number-of", "type": "clause", "offset": [54, 63]}], "hash": "5488e96f93e9b16573820e4c68f65852", "id": 2}, {"size": 21, "samples": [{"hash": "bomb1TB2jkC", "uri": "/contracts/bomb1TB2jkC#fte-cost", "label": "Research Collaboration and License Agreement (Context Therapeutics LLC)", "score": 32.3347015381, "published": true}, {"hash": "d3dgj0N3XOW", "uri": "/contracts/d3dgj0N3XOW#fte-cost", "label": "Collaboration and License Agreement (Epizyme, Inc.)", "score": 24.3620815277, "published": true}, {"hash": "8gmrZeLynE7", "uri": "/contracts/8gmrZeLynE7#fte-cost", "label": "Collaboration and License Agreement (Epizyme, Inc.)", "score": 24.3620815277, "published": true}], "snippet": "means, for any period, the product of (a) the actual total FTEs (or applicable portion thereof) during such period, and (b) the FTE Rate.", "snippet_links": [{"key": "the-product", "type": "definition", "offset": [23, 34]}, {"key": "applicable-portion", "type": "definition", "offset": [68, 86]}, {"key": "fte-rate", "type": "definition", "offset": [128, 136]}], "hash": "97685640227304320d31335a875572d8", "id": 3}, {"size": 15, "samples": [{"hash": "8uOJzHOzHTg", "uri": "/contracts/8uOJzHOzHTg#fte-cost", "label": "Multi Target Agreement (Immunogen Inc)", "score": 29.3504447937, "published": true}, {"hash": "jQ42BsHSUjC", "uri": "/contracts/jQ42BsHSUjC#fte-cost", "label": "Multi Target Agreement (Immunogen Inc)", "score": 26.6290206909, "published": true}, {"hash": "1dOF1noIYvX", "uri": "/contracts/1dOF1noIYvX#fte-cost", "label": "Multi Target Agreement (Immunogen Inc)", "score": 26.6290206909, "published": true}], "snippet": "means, for any period during the Term, the FTE Rate multiplied by the number of FTEs expended over such period.", "snippet_links": [{"key": "during-the-term", "type": "clause", "offset": [22, 37]}, {"key": "fte-rate", "type": "definition", "offset": [43, 51]}, {"key": "number-of", "type": "clause", "offset": [70, 79]}], "hash": "5e3741169ae632986d8b65eeab7bb860", "id": 4}, {"size": 11, "samples": [{"hash": "lNYrtxpSCEZ", "uri": "/contracts/lNYrtxpSCEZ#fte-cost", "label": "Collaboration and License Agreement (Zai Lab LTD)", "score": 32.603012085, "published": true}, {"hash": "hZ4t2oTkw2D", "uri": "/contracts/hZ4t2oTkw2D#fte-cost", "label": "Collaboration and License Agreement (Macrogenics Inc)", "score": 32.57289505, "published": true}, {"hash": "lxfjxuf8CK6", "uri": "http://ir.macrogenics.com/static-files/26c45914-05f5-4c1d-a58c-62d342129a6a", "label": "ir.macrogenics.com", "score": 8.786447525, "published": false}], "snippet": "means, with respect to any period and a Party or its Affiliate, the FTE Rate multiplied by the number of FTEs expended by such Party or its Affiliate during such period; provided that a Party shall not charge the other Party more than once for any FTE Cost if such FTE Cost is already included as a component of other expenses payable to such charging Party under this Agreement.", "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "a-party", "type": "clause", "offset": [38, 45]}, {"key": "fte-rate", "type": "definition", "offset": [68, 76]}, {"key": "number-of", "type": "clause", "offset": [95, 104]}, {"key": "such-party", "type": "clause", "offset": [122, 132]}, {"key": "provided-that", "type": "definition", "offset": [170, 183]}, {"key": "other-party", "type": "definition", "offset": [213, 224]}, {"key": "payable-to", "type": "definition", "offset": [327, 337]}, {"key": "charging-party", "type": "definition", "offset": [343, 357]}, {"key": "this-agreement", "type": "clause", "offset": [364, 378]}], "hash": "83937a5d487369bc1a2b7b0678cad021", "id": 5}, {"size": 9, "samples": [{"hash": "4kdmCgnEV4b", "uri": "/contracts/4kdmCgnEV4b#fte-cost", "label": "Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc)", "score": 32.0965080261, "published": true}, {"hash": "fznsThnAVdv", "uri": "/contracts/fznsThnAVdv#fte-cost", "label": "Collaborative Development & License Agreement", "score": 31.3390369415, "published": true}, {"hash": "23GorjdgR8Q", "uri": "/contracts/23GorjdgR8Q#fte-cost", "label": "Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc)", "score": 27.1054077148, "published": true}], "snippet": "means, for any Calendar Quarter during the Research Program Term, the FTE Rate divided by 4, multiplied by the applicable number of FTEs applied during such Calendar Quarter.", "snippet_links": [{"key": "calendar-quarter", "type": "definition", "offset": [15, 31]}, {"key": "during-the-research-program-term", "type": "clause", "offset": [32, 64]}, {"key": "fte-rate", "type": "definition", "offset": [70, 78]}, {"key": "divided-by", "type": "clause", "offset": [79, 89]}, {"key": "number-of", "type": "clause", "offset": [122, 131]}], "hash": "a16ddf02e98d92667cf871202d053a2e", "id": 6}, {"size": 9, "samples": [{"hash": "1LAjMh1b9DU", "uri": "/contracts/1LAjMh1b9DU#fte-cost", "label": "Development and License Agreement (Immunogen Inc)", "score": 29.3504447937, "published": true}, {"hash": "gnUurnztu4S", "uri": "/contracts/gnUurnztu4S#fte-cost", "label": "Development and License Agreement (Immunogen Inc)", "score": 23.773443222, "published": true}, {"hash": "eZ95qB5Yhcg", "uri": "/contracts/eZ95qB5Yhcg#fte-cost", "label": "Development and License Agreement (Immunogen Inc)", "score": 23.3545513153, "published": true}], "snippet": "means, for any period during the Term of this Agreement, the FTE Rate multiplied by the number of FTEs expended over such period.", "snippet_links": [{"key": "during-the-term-of-this-agreement", "type": "clause", "offset": [22, 55]}, {"key": "fte-rate", "type": "definition", "offset": [61, 69]}, {"key": "number-of", "type": "clause", "offset": [88, 97]}], "hash": "0c17343b4e9966c84d3617af4b507ee8", "id": 7}, {"size": 6, "samples": [{"hash": "toyNMkJhal", "uri": "/contracts/toyNMkJhal#fte-cost", "label": "License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)", "score": 34.1444206238, "published": true}, {"hash": "8wkFXVcAmCH", "uri": "/contracts/8wkFXVcAmCH#fte-cost", "label": "Development and Marketing Agreement", "score": 27.0520191193, "published": true}, {"hash": "h4IzP3EHexR", "uri": "/contracts/h4IzP3EHexR#fte-cost", "label": "License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)", "score": 24.5646820068, "published": true}], "snippet": "means, for any period, the FTE Rate multiplied by the number of FTEs in such period; provided, however, that for purposes of such calculation, no individual may account for more than one FTE in any Calendar Year.", "snippet_links": [{"key": "fte-rate", "type": "definition", "offset": [27, 35]}, {"key": "number-of", "type": "clause", "offset": [54, 63]}, {"key": "for-purposes-of", "type": "clause", "offset": [109, 124]}, {"key": "may-account", "type": "definition", "offset": [157, 168]}, {"key": "calendar-year", "type": "definition", "offset": [198, 211]}], "hash": "dbc2d7b4a0018aaaa385de06d54a5de7", "id": 8}, {"size": 5, "samples": [{"hash": "7wSU09vhieX", "uri": "/contracts/7wSU09vhieX#fte-cost", "label": "Collaboration and License Agreement (Amgen Inc)", "score": 35.1190948486, "published": true}, {"hash": "2PhDafSC7rS", "uri": "/contracts/2PhDafSC7rS#fte-cost", "label": "Collaboration and License Agreement (Amgen Inc)", "score": 24.578371048, "published": true}, {"hash": "bw8hj4AaBZ0", "uri": "/contracts/bw8hj4AaBZ0#fte-cost", "label": "Collaboration and License Agreement (Amgen Inc)", "score": 24.1567420959, "published": true}], "snippet": "means, for any quarter, the FTE Rate multiplied by the sum of the number of days (calculated by adding the full and partial percentage of days) actually spent in that quarter by FTEs of a Party working directly on Research and Development of Antibody Products under the terms of this Agreement (as per their time sheets) divided by [*].", "snippet_links": [{"key": "fte-rate", "type": "definition", "offset": [28, 36]}, {"key": "sum-of", "type": "clause", "offset": [55, 61]}, {"key": "number-of-days", "type": "definition", "offset": [66, 80]}, {"key": "a-party", "type": "clause", "offset": [186, 193]}, {"key": "development-of", "type": "clause", "offset": [227, 241]}, {"key": "terms-of-this-agreement", "type": "clause", "offset": [270, 293]}, {"key": "time-sheets", "type": "clause", "offset": [308, 319]}, {"key": "divided-by", "type": "clause", "offset": [321, 331]}], "hash": "1b3c612299da4a150e6fc991e1cbc025", "id": 9}, {"size": 5, "samples": [{"hash": "ikALJ3zbg37", "uri": "/contracts/ikALJ3zbg37#fte-cost", "label": "Joint Commercialization Agreement (Seattle Genetics Inc /Wa)", "score": 30.5359344482, "published": true}, {"hash": "9v2axl0XhQa", "uri": "https://d18rn0p25nwr6d.cloudfront.net/CIK-0001060736/7db20917-9a45-49c0-8846-ae68266dd616.pdf", "label": "d18rn0p25nwr6d.cloudfront.net", "score": 11.4544830322, "published": false}], "snippet": "means the cost of an FTE based on the FTE rate applicable to such FTE determined from time to time in accordance with the Collaboration Agreement.", "snippet_links": [{"key": "cost-of", "type": "definition", "offset": [10, 17]}, {"key": "based-on", "type": "definition", "offset": [25, 33]}, {"key": "applicable-to", "type": "definition", "offset": [47, 60]}, {"key": "from-time-to-time", "type": "clause", "offset": [81, 98]}, {"key": "in-accordance-with", "type": "definition", "offset": [99, 117]}, {"key": "collaboration-agreement", "type": "definition", "offset": [122, 145]}], "hash": "5621f8e3d6612a9dc0895a8cf9431e12", "id": 10}], "next_curs": "ClUST2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjELEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIRZnRlLWNvc3QjMDAwMDAwMGEMogECZW4YACAA", "definition": {"size": 272, "snippet": "means, for any period, the FTE Rate multiplied by the applicable number of FTEs in such period.", "title": "FTE Cost", "id": "fte-cost", "examples": ["Furthermore, the sum total payments made by Apollomics to reimburse E\u2587\u2587\u2587\u2587\u2587\u2019s costs pursuant to this Section 4.4 (including (i) <strong>FTE Cost</strong> and out-of-pocket costs paid by Edison for conducting the Initial Clinical Trial, (ii) the Prior Payments, and (iii) all other payments due under this Amendment) shall not exceed USD $[***] without prior written consent of the Parties."], "related": [["fte-costs", "FTE Costs", "<strong>FTE Costs</strong>"], ["development-cost", "Development Cost", "Development Cost"], ["fte", "FTE", "FTE"], ["total-development-cost", "Total Development Cost", "Total Development Cost"], ["allowable-cost", "Allowable cost", "Allowable cost"]], "related_snippets": [], "updated": "2026-05-24T04:25:30+00:00"}, "json": true, "cursor": ""}}